AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 34814933 — intervention group
Group type: EXPERIMENTAL
Intervention: Tenofovir/lamivudine (TDF/3TC) plus atazanavir/ritonavir (ATV/r)
Number of subjects: 24
Study 32425006 — intervention group
Group type: EXPERIMENTAL
Intervention: Internet-based integrated intervention
Number of subjects: 0
Study 35470916 — intervention group
Group type: EXPERIMENTAL
Intervention: Crocin (15 mg, twice daily)
Number of subjects: 50
Study 35470916 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study 33394881 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic exercise intervention (18 sessions)
Number of subjects: 83
Study 33394881 — intervention group
Group type: COMPARATOR
Intervention: Usual activity control
Number of subjects: 83
Study 33394881 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic exercise intervention
Number of subjects: 83
Study 34009900 — intervention group
Group type: EXPERIMENTAL
Intervention: Video-guided assistance (U-V, T-V)
Number of subjects: 120
Study 34009900 — intervention group
Group type: COMPARATOR
Intervention: Telephone-guided assistance (U-T, T-T)
Number of subjects: 120
Study 34009900 — intervention group
Group type: EXPERIMENTAL
Intervention: Trained telephone-guided (T-T)
Number of subjects: 120
Study 34009900 — intervention group
Group type: EXPERIMENTAL
Intervention: Video-guided (T-V)
Number of subjects: 120
Study 34009900 — intervention group
Group type: EXPERIMENTAL
Intervention: Untrained video-guided (U-V)
Number of subjects: 120
Study 34009900 — intervention group
Group type: COMPARATOR
Intervention: Untrained telephone-guided (U-T)
Number of subjects: 120
Study 34009900 — intervention group
Group type: EXPERIMENTAL
Intervention: Trained video-guided (T-V)
Number of subjects: 120
Study 34009900 — intervention group
Group type: EXPERIMENTAL
Intervention: Video groups (U-V, T-V)
Number of subjects: 120
Study 33930401 — intervention group
Group type: EXPERIMENTAL
Intervention: Full CIC membrane GC count using cell-counting software
Number of subjects: 32
Study 33930401 — intervention group
Group type: EXPERIMENTAL
Intervention: Partial membrane GC count using cell-counting software
Number of subjects: 32
Study 33930401 — intervention group
Group type: EXPERIMENTAL
Intervention: Manual counting of the 25 images
Number of subjects: 32
Study 33930401 — intervention group
Group type: EXPERIMENTAL
Intervention: Comparison of GCD values between full and manual methods
Number of subjects: 32
Study 33930401 — intervention group
Group type: EXPERIMENTAL
Intervention: Comparison of GCD values between full and partial methods
Number of subjects: 32
Study 33930401 — intervention group
Group type: COMPARATOR
Intervention: Storage duration (2–3 weeks vs 6–7 weeks)
Number of subjects: 32
Study 33930401 — intervention group
Group type: COMPARATOR
Intervention: Storage container types (microcentrifuge tube vs flat histology cassette)
Number of subjects: 32
Study 36000550 — intervention group
Group type: EXPERIMENTAL
Intervention: Accumed NF60 nebulizer
Number of subjects: 32
Study 36000550 — intervention group
Group type: COMPARATOR
Intervention: Allegro nebulizer
Number of subjects: 32
Study 32013681 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium control during post-dilution online hemodiafiltration treatments
Number of subjects: 81
Study 32013681 — intervention group
Group type: COMPARATOR
Intervention: Isolated ultrafiltration for the first 90 minutes followed by sodium control during post-dilution online hemodiafiltration
Number of subjects: 81
Study 36463355 — intervention group
Group type: EXPERIMENTAL
Intervention: Specialist palliative care intervention
Number of subjects: 0
Study 36463355 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study 33838536 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound-guided erector spinae plane block with local anesthetic (10 mL of 1% lidocaine + 10 mL of 0.5% bupivacaine)
Number of subjects: 50
Study 33838536 — intervention group
Group type: COMPARATOR
Intervention: Placebo injection
Number of subjects: 50
Study 33838536 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound-guided erector spinae plane block
Number of subjects: 50
Study 34319670 — intervention group
Group type: EXPERIMENTAL
Intervention: Mini‐Five Gracey Curettes (MFC)
Number of subjects: 20
Study 34319670 — intervention group
Group type: COMPARATOR
Intervention: Conventional Gracey Curettes (CGC)
Number of subjects: 20
Study 35611492 — intervention group
Group type: EXPERIMENTAL
Intervention: Neurofeedback-based neuropsychotherapy (20-hour combined computerized training program)
Number of subjects: 50
Study 35611492 — intervention group
Group type: COMPARATOR
Intervention: Wait-list control group (CON)
Number of subjects: 50
Study 33757158 — intervention group
Group type: EXPERIMENTAL
Intervention: Fronto-parieto-occipital tACS (alpha-frequency in-phase)
Number of subjects: 24
Study 33757158 — intervention group
Group type: EXPERIMENTAL
Intervention: Fronto-parieto-occipital tACS (alpha-frequency antiphase)
Number of subjects: 24
Study 33757158 — intervention group
Group type: COMPARATOR
Intervention: Fronto-parieto-occipital tACS (gamma frequency antiphase control)
Number of subjects: 24
Study 33757158 — intervention group
Group type: EXPERIMENTAL
Intervention: tACS responders
Number of subjects: 24
Study 33757158 — intervention group
Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 24
Study 32556001 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness-based intervention plus treatment as usual
Number of subjects: 42
Study 32556001 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual
Number of subjects: 42
Study 33982590 — intervention group
Group type: EXPERIMENTAL
Intervention: NMES‐RT
Number of subjects: 33
Study 33982590 — intervention group
Group type: COMPARATOR
Intervention: PMT
Number of subjects: 33
Study 32506371 — intervention group
Group type: EXPERIMENTAL
Intervention: Minocycline 400 mg orally twice a day with bevacizumab 10 mg/kg IV every two weeks and reirradiation
Number of subjects: 10
Study 34649960 — intervention group
Group type: EXPERIMENTAL
Intervention: Multicomponent intervention including brief telephone and print education, delivered in multiple languages, and personalized referral to a low-cost/free vaccine provider
Number of subjects: 238
Study 34649960 — intervention group
Group type: COMPARATOR
Intervention: Routine practice (Control)
Number of subjects: 238
Study 34649960 — intervention group
Group type: EXPERIMENTAL
Intervention: Both intervention and control groups
Number of subjects: 238
Study 33908377 — intervention group
Group type: EXPERIMENTAL
Intervention: Stimulant diversion prevention intervention
Number of subjects: 341
Study 33908377 — intervention group
Group type: EXPERIMENTAL
Intervention: Older age
Number of subjects: 341
Study 33908377 — intervention group
Group type: EXPERIMENTAL
Intervention: Treatment disclosure
Number of subjects: 341
Study 33908377 — intervention group
Group type: EXPERIMENTAL
Intervention: Tolerance for stimulant misuse and diversion
Number of subjects: 341
Study 33908377 — intervention group
Group type: EXPERIMENTAL
Intervention: Peer norms favorable to stimulant misuse and diversion
Number of subjects: 341
Study 35933897 — intervention group
Group type: EXPERIMENTAL
Intervention: 250 mg shilajit extract
Number of subjects: 60
Study 35933897 — intervention group
Group type: EXPERIMENTAL
Intervention: 500 mg shilajit extract
Number of subjects: 60
Study 35933897 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study 35900838 — intervention group
Group type: EXPERIMENTAL
Intervention: Patiromer
Number of subjects: 878
Study 35900838 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 878
Study 32717289 — intervention group
Group type: EXPERIMENTAL
Intervention: Obeticholic acid (OCA)
Number of subjects: 8
Study 32717289 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study 32293045 — intervention group
Group type: EXPERIMENTAL
Intervention: Fractional CO2 laser
Number of subjects: 30
Study 32293045 — intervention group
Group type: EXPERIMENTAL
Intervention: Nd:YAG laser
Number of subjects: 30
Study 32293045 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined CO2 and Nd:YAG lasers
Number of subjects: 30
Study 32293045 — intervention group
Group type: COMPARATOR
Intervention: All treatment modalities
Number of subjects: 30
Study 34353615 — intervention group
Group type: EXPERIMENTAL
Intervention: Olaparib 300 mg twice daily
Number of subjects: 391
Study 34353615 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 391
Study 33267558 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive Lifestyle Intervention (ILI)
Number of subjects: 5145
Study 33267558 — intervention group
Group type: COMPARATOR
Intervention: Diabetes Support and Education (DSE)
Number of subjects: 5145
Study 34984539 — intervention group
Group type: EXPERIMENTAL
Intervention: GEN0101 (low dose: 30,000 mNAU)
Number of subjects: 6
Study 34984539 — intervention group
Group type: EXPERIMENTAL
Intervention: GEN0101 (high dose: 60,000 mNAU)
Number of subjects: 6
Study 34984539 — intervention group
Group type: EXPERIMENTAL
Intervention: GEN0101 (combined results)
Number of subjects: 6
Study 34984539 — intervention group
Group type: EXPERIMENTAL
Intervention: GEN0101
Number of subjects: 6
Study 33450656 — intervention group
Group type: EXPERIMENTAL
Intervention: Starch‐ and sucrose‐reduced diet (SSRD) for 4 weeks
Number of subjects: 105
Study 33450656 — intervention group
Group type: COMPARATOR
Intervention: Ordinary diet
Number of subjects: 105
Study 32779197 — intervention group
Group type: EXPERIMENTAL
Intervention: Infant Motor Activity Log (IMAL) for children with impairments
Number of subjects: 66
Study 32779197 — intervention group
Group type: COMPARATOR
Intervention: Infant Motor Activity Log (IMAL) for typically developing infants
Number of subjects: 66
Study 35176134 — intervention group
Group type: EXPERIMENTAL
Intervention: Mini-dose glucagon (MDG)
Number of subjects: 17
Study 35176134 — intervention group
Group type: COMPARATOR
Intervention: Oral glucose tablets (OG)
Number of subjects: 17
Study 32468649 — intervention group
Group type: EXPERIMENTAL
Intervention: Lemborexant 5 mg
Number of subjects: 151
Study 32468649 — intervention group
Group type: EXPERIMENTAL
Intervention: Lemborexant 10 mg
Number of subjects: 151
Study 32468649 — intervention group
Group type: EXPERIMENTAL
Intervention: Lemborexant 10 mg/day
Number of subjects: 151
Study 32468649 — intervention group
Group type: EXPERIMENTAL
Intervention: Lemborexant (doses through 25 mg)
Number of subjects: 151
Study 32468649 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 151
Study 32790051 — intervention group
Group type: EXPERIMENTAL
Intervention: Symptom-tracking app group
Number of subjects: 91
Study 32790051 — intervention group
Group type: COMPARATOR
Intervention: Calendar app group
Number of subjects: 91
Study 32790051 — intervention group
Group type: COMPARATOR
Intervention: No app control group
Number of subjects: 91
Study 32790051 — intervention group
Group type: EXPERIMENTAL
Intervention: General symptom reporting across all groups
Number of subjects: 91
Study 34888654 — intervention group
Group type: EXPERIMENTAL
Intervention: Pulse dexamethasone (3 mg/kg/day, max 100 mg/day)
Number of subjects: 60
Study 34888654 — intervention group
Group type: COMPARATOR
Intervention: Placebo (normal saline)
Number of subjects: 60
Study 32401981 — intervention group
Group type: EXPERIMENTAL
Intervention: Pcv‐aCO2/Ca‐cvO2 > 1.4
Number of subjects: 0
Study 32401981 — intervention group
Group type: COMPARATOR
Intervention: Pcv‐aCO2/Ca‐cvO2
Number of subjects: 0
Study 33807319 — intervention group
Group type: EXPERIMENTAL
Intervention: Reduced calorie diet provided by a whole-diet replacement
Number of subjects: 0
Study 33807319 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study 34981622 — intervention group
Group type: EXPERIMENTAL
Intervention: Bempedoic acid 180 mg once daily
Number of subjects: 3621
Study 34981622 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 3621
Study 33459833 — intervention group
Group type: EXPERIMENTAL
Intervention: 6-week return to full weight bearing (WB)
Number of subjects: 35
Study 33459833 — intervention group
Group type: COMPARATOR
Intervention: 8-week return to full weight bearing (WB)
Number of subjects: 35
Study 32590968 — intervention group
Group type: EXPERIMENTAL
Intervention: < 3 hours/week exercise
Number of subjects: 124
Study 32590968 — intervention group
Group type: EXPERIMENTAL
Intervention: Feeling not fit
Number of subjects: 124
Study 32590968 — intervention group
Group type: EXPERIMENTAL
Intervention: Overweight
Number of subjects: 124
Study 32590968 — intervention group
Group type: EXPERIMENTAL
Intervention: VO2max distribution
Number of subjects: 124
Study 32590968 — intervention group
Group type: EXPERIMENTAL
Intervention: Levels of exercise, self-assessed fitness, and BMI
Number of subjects: 124
Study 35334548 — intervention group
Group type: EXPERIMENTAL
Intervention: Specialized physical therapy with partial body weight supported treadmill training
Number of subjects: 30
Study 35334548 — intervention group
Group type: COMPARATOR
Intervention: Specialized physical therapy without partial body weight supported treadmill training
Number of subjects: 30
Study 32692425 — intervention group
Group type: EXPERIMENTAL
Intervention: Cannabis use at age 14
Number of subjects: 583
Study 32692425 — intervention group
Group type: EXPERIMENTAL
Intervention: Tobacco use at age 14
Number of subjects: 583
Study 32361773 — intervention group
Group type: EXPERIMENTAL
Intervention: Curcuma longa L. extract (CLE) 3 capsules per day, 500 mg each
Number of subjects: 28
Study 32361773 — intervention group
Group type: COMPARATOR
Intervention: Placebo (PLA) 3 capsules per day, 500 mg of microcrystalline cellulose
Number of subjects: 28
Study 36451343 — intervention group
Group type: EXPERIMENTAL
Intervention: Erlotinib plus bevacizumab (in patients with brain metastasis)
Number of subjects: 127
Study 36451343 — intervention group
Group type: COMPARATOR
Intervention: Erlotinib (in patients with brain metastasis)
Number of subjects: 127
Study 33268410 — intervention group
Group type: EXPERIMENTAL
Intervention: Azithromycin treatment
Number of subjects: 347
Study 35301941 — intervention group
Group type: EXPERIMENTAL
Intervention: eHealth hearing aid management education program
Number of subjects: 78
Study 35301941 — intervention group
Group type: COMPARATOR
Intervention: treatment-as-usual (TAU)
Number of subjects: 78
Study 34257152 — intervention group
Group type: EXPERIMENTAL
Intervention: Current HTP users
Number of subjects: 7000
Study 34257152 — intervention group
Group type: EXPERIMENTAL
Intervention: Stealth use of HTPs
Number of subjects: 7000
Study 34257152 — intervention group
Group type: EXPERIMENTAL
Intervention: Dual cigarette users (HTPs and electronic cigarettes)
Number of subjects: 7000
Study 34257152 — intervention group
Group type: EXPERIMENTAL
Intervention: Triple users (HTPs, ECs, and combustible cigarettes)
Number of subjects: 7000
Study 34257152 — intervention group
Group type: EXPERIMENTAL
Intervention: Agreement with allowing indoor HTP use
Number of subjects: 7000
Study 32275031 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical administration of papaverine with left stellate ganglion blockade (LSGB)
Number of subjects: 100
Study 32275031 — intervention group
Group type: COMPARATOR
Intervention: Topical administration of papaverine alone (Control Group-C)
Number of subjects: 100
Study 32275031 — intervention group
Group type: EXPERIMENTAL
Intervention: Left stellate ganglion blockade (LSGB)
Number of subjects: 100
Study 34391687 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous nicorandil application plus routine care
Number of subjects: 147
Study 34391687 — intervention group
Group type: COMPARATOR
Intervention: Control group (conventional diuretics, positive inotropic agents, and related therapy according to the guidelines)
Number of subjects: 147
Study 34121734 — intervention group
Group type: EXPERIMENTAL
Intervention: Xylocaine + MgSO4
Number of subjects: 0
Study 34121734 — intervention group
Group type: COMPARATOR
Intervention: Xylocaine
Number of subjects: 0
Study 32379303 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention Group
Number of subjects: 329
Study 32379303 — intervention group
Group type: COMPARATOR
Intervention: Control Group
Number of subjects: 329
Study 33285548 — intervention group
Group type: EXPERIMENTAL
Intervention: Amine fluoride/sodium fluoride (12,500 ppm F; pH = 4.4; AmF)
Number of subjects: 240
Study 33285548 — intervention group
Group type: EXPERIMENTAL
Intervention: NaF (12,500 ppm; pH = 6.6; NaF1)
Number of subjects: 240
Study 33285548 — intervention group
Group type: EXPERIMENTAL
Intervention: NaF (12,500 ppm; pH = 6.3; NaF2)
Number of subjects: 240
Study 33285548 — intervention group
Group type: EXPERIMENTAL
Intervention: Silver diamine fluoride (14,200 ppm; pH = 8.7; SDF)
Number of subjects: 240
Study 33285548 — intervention group
Group type: EXPERIMENTAL
Intervention: Acidulated phosphate fluoride (12,500 ppm; pH = 3.8; APF)
Number of subjects: 240
Study 33285548 — intervention group
Group type: EXPERIMENTAL
Intervention: Highly fluoridated dentifrice (5,000 ppm)
Number of subjects: 240
Study 33285548 — intervention group
Group type: COMPARATOR
Intervention: Standard control (no intervention)
Number of subjects: 240
Study 32331019 — intervention group
Group type: EXPERIMENTAL
Intervention: HP-3070 high-dose
Number of subjects: 616
Study 32331019 — intervention group
Group type: EXPERIMENTAL
Intervention: HP-3070 low-dose
Number of subjects: 616
Study 32331019 — intervention group
Group type: COMPARATOR
Intervention: Placebo (PBO)
Number of subjects: 616
Study 32847397 — intervention group
Group type: EXPERIMENTAL
Intervention: Device-guided slow breathing (DGB) for 8 weeks (n = 12)
Number of subjects: 25
Study 32847397 — intervention group
Group type: COMPARATOR
Intervention: Sham device for 8 weeks (n = 13)
Number of subjects: 25
Study 35272029 — intervention group
Group type: EXPERIMENTAL
Intervention: Corticosteroids + mesalamine (4 g/day)
Number of subjects: 149
Study 35272029 — intervention group
Group type: COMPARATOR
Intervention: Corticosteroids alone
Number of subjects: 149
Study 35272029 — intervention group
Group type: EXPERIMENTAL
Intervention: Corticosteroids + mesalamine
Number of subjects: 149
Study 32816563 — intervention group
Group type: EXPERIMENTAL
Intervention: Revised registration documents
Number of subjects: 172
Study 32816563 — intervention group
Group type: EXPERIMENTAL
Intervention: Changes in study characteristics
Number of subjects: 172
Study 32816563 — intervention group
Group type: COMPARATOR
Intervention: Publications affected by revisions
Number of subjects: 172
Study 32098767 — intervention group
Group type: EXPERIMENTAL
Intervention: Anastrozole
Number of subjects: 247
Study 32098767 — intervention group
Group type: COMPARATOR
Intervention: Exemestane
Number of subjects: 247
Study 32098767 — intervention group
Group type: COMPARATOR
Intervention: Letrozole
Number of subjects: 247
Study 35525414 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic Anatomical Hepatectomy (LAH)
Number of subjects: 385
Study 35525414 — intervention group
Group type: COMPARATOR
Intervention: Laparoscopic Non-anatomical Hepatectomy (LNAH)
Number of subjects: 385
Study 34120942 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical exercise (PE)
Number of subjects: 0
Study 34120942 — intervention group
Group type: COMPARATOR
Intervention: Non-physical exercise
Number of subjects: 0
Study 34669036 — intervention group
Group type: EXPERIMENTAL
Intervention: Xbox Kinect group (VR training)
Number of subjects: 60
Study 34669036 — intervention group
Group type: EXPERIMENTAL
Intervention: Resistance exercise group
Number of subjects: 60
Study 33287773 — intervention group
Group type: EXPERIMENTAL
Intervention: Anterolateral acromioplasty
Number of subjects: 60
Study 33287773 — intervention group
Group type: EXPERIMENTAL
Intervention: Lateral acromioplasty
Number of subjects: 60
Study 33287773 — intervention group
Group type: EXPERIMENTAL
Intervention: Precise acromioplasty
Number of subjects: 60
Study 35972832 — intervention group
Group type: EXPERIMENTAL
Intervention: Complex behavioural change intervention combining behaviour change communication and access to a habit formation mobile application
Number of subjects: 549
Study 35972832 — intervention group
Group type: COMPARATOR
Intervention: Standard care provided by public health clinics in Malaysia
Number of subjects: 549
Study 35972832 — intervention group
Group type: EXPERIMENTAL
Intervention: Complex behavioural change intervention
Number of subjects: 549
Study 34117592 — intervention group
Group type: EXPERIMENTAL
Intervention: Dapivirine vaginal ring
Number of subjects: 0
Study 34117592 — intervention group
Group type: COMPARATOR
Intervention: Placebo (control)
Number of subjects: 0
Study 32709005 — intervention group
Group type: EXPERIMENTAL
Intervention: Healthy Me one‐year program (multicomponent intervention using multimedia technologies)
Number of subjects: 1111
Study 36094813 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard 8-session web-based mindfulness-based cognitive therapy (MBCT)
Number of subjects: 4411
Study 36094813 — intervention group
Group type: COMPARATOR
Intervention: Brief 3-session mindfulness training intervention
Number of subjects: 4411
Study 36094813 — intervention group
Group type: COMPARATOR
Intervention: Comparison of MBCT vs brief mindfulness
Number of subjects: 4411
Study 33596771 — intervention group
Group type: EXPERIMENTAL
Intervention: Increased cadence (CAD)
Number of subjects: 33
Study 33596771 — intervention group
Group type: EXPERIMENTAL
Intervention: Forefoot strike (FFS)
Number of subjects: 33
Study 33132302 — intervention group
Group type: EXPERIMENTAL
Intervention: New scoring system for predicting clinical severity and prognosis of COVID-19
Number of subjects: 444
Study 33132302 — intervention group
Group type: EXPERIMENTAL
Intervention: New scoring system for predicting severe cases of COVID-19
Number of subjects: 444
Study 36043918 — intervention group
Group type: EXPERIMENTAL
Intervention: STOP-BANG questionnaire
Number of subjects: 200
Study 36043918 — intervention group
Group type: EXPERIMENTAL
Intervention: Other difficult airway determinant tests
Number of subjects: 200
Study 34165999 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness of Breath (MoB)
Number of subjects: 118
Study 34165999 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness of Pain (MoP)
Number of subjects: 118
Study 34165999 — intervention group
Group type: COMPARATOR
Intervention: Cognitive-Behavioral pain psychoeducation (CB)
Number of subjects: 118
Study 32113994 — intervention group
Group type: EXPERIMENTAL
Intervention: Steroid therapy (dexamethasone 4 mg three times daily for 5 days)
Number of subjects: 532
Study 32113994 — intervention group
Group type: COMPARATOR
Intervention: Conservative management
Number of subjects: 532
Study 34543422 — intervention group
Group type: EXPERIMENTAL
Intervention: Training and tool kit (Arm 1)
Number of subjects: 26
Study 34543422 — intervention group
Group type: EXPERIMENTAL
Intervention: Training and tool kit plus referral system to CHW (Arm 2)
Number of subjects: 26
Study 34543422 — intervention group
Group type: EXPERIMENTAL
Intervention: Both Arm 1 and Arm 2
Number of subjects: 26